Loading…
Loading…
DHR · NYSE · Healthcare
“At 37 times earnings, Danaher's valuation demands exceptional growth certainty that prudent investors should question given the inherent unpredictability of business cycles.”
— In the voice of Graham
Track upcoming IPOs for the next three months. Filter by sector and expected valuation range.
Market Cap
$135.27B
P/E Ratio
37.43
Forward P/E
—
EPS
$5.07
PEG Ratio
2.95
Book Value
$73.71
Dividend Yield
0.64%
Profit Margin
14.71%
ROE
6.88%
Use the interactive ipo calendar with pre-loaded data for Danaher Corp. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for DHR: